BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Response to oxidative stress
,
Obesity
,
Intestine
,
Neocentromeres
,
Vitamin E
,
MYC
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
protozoan vaccines
(compound)
NextBio Summary
General Info
Genetic Markers
Most Correlated Genes
CXCL8
SERPING1
CXCL10
TFEC
GBP1P1
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
NUYTTEN_EZH2_TARGETS_UP
GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_DN
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
PILON_KLF1_TARGETS_DN
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
PBMC expression data from a malaria vaccine trial
Whole blood of subjects with ChAd63-KH leishmaniasis vaccination
Blood of subjects before and after Plasmodium falciparum sporozoite vaccination
Explore Curated Studies Results
Literature
Most Relevant Literature
Toxoplasma gondii-Current drugs and future vaccines against an underestimated protozoan infection].
A safe, effective, and reliable vaccine against Chagas disease should be described
High-throughput hit-squad tackles trypanosomes.
Em14-3-3 delivered by PLGA and chitosan nanoparticles conferred improved protection in chicken again…
Evaluation of live-attenuated Histomonas meleagridis isolates as vaccine candidates against wild-typ…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Parasitism & COVID19 Vaccines: New Challenge.
LEISH-F3 + GLA-SE and the LEISH-F3 + MPL-SE Vaccine
EP1300 Polyepitope DNA Vaccine Against Plasmodium Falciparum Malaria
Safety/Efficacy Trial of Killed Leishmania Vaccine in Volunteers With no Response to Leishmanin
Safety and Immunogenicity of a Vaccine for Cutaneous Leishmaniasis Using Recombinant Human Interleuk…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ